PubRank

John Waldron

Author PubWeight™ 51.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 2013 3.76
2 Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010 2.79
3 Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 2009 2.74
4 MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 2011 2.15
5 Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure. Oral Oncol 2012 1.98
6 Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys 2005 1.54
7 Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2010 1.49
8 Response to letter to the editor with reference to article "Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure". Oral Oncol 2013 1.40
9 Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int J Cancer 2010 1.38
10 Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers. Int J Radiat Oncol Biol Phys 2007 1.20
11 Screening for depression in head and neck cancer. Psychooncology 2004 1.14
12 Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma. Clin Cancer Res 2013 1.13
13 Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin Cancer Res 2011 1.11
14 Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway. Oncotarget 2012 1.09
15 No evidence for improved TORS post-treatment feeding tube dependency rate relative to standard therapy in early stage oropharyngeal cancer. Oral Oncol 2015 1.07
16 Patterns of care in elderly head-and-neck cancer radiation oncology patients: a single-center cohort study. Int J Radiat Oncol Biol Phys 2010 1.03
17 Genetic polymorphisms and head and neck cancer outcomes: a review. Cancer Epidemiol Biomarkers Prev 2008 1.02
18 A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy. Cancer 2014 1.02
19 Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? Lung Cancer 2005 1.00
20 Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status. Int J Radiat Oncol Biol Phys 2004 0.98
21 Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma. Clin Cancer Res 2003 0.97
22 Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia. Head Neck 2012 0.96
23 Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer. Radiother Oncol 2007 0.96
24 Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy. Mol Cell Proteomics 2012 0.92
25 Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status. Head Neck 2013 0.91
26 Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2010 0.90
27 Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010 0.90
28 Preoperative radiotherapy for adult head and neck soft tissue sarcoma: assessment of wound complication rates and cancer outcome in a prospective series. World J Surg 2003 0.89
29 Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status. Int J Radiat Oncol Biol Phys 2013 0.89
30 The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre. Cancer Epidemiol 2013 0.88
31 Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients. Cancer 2013 0.84
32 Truths and myths about radiotherapy for verrucous carcinoma of larynx. Int J Radiat Oncol Biol Phys 2008 0.84
33 Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival. Clin Cancer Res 2011 0.84
34 Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary? Radiother Oncol 2002 0.84
35 Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers. Cancer 2011 0.83
36 Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial. Radiother Oncol 2008 0.83
37 Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients. Oral Oncol 2013 0.82
38 Efficacy of combining GMX1777 with radiation therapy for human head and neck carcinoma. Clin Cancer Res 2010 0.82
39 Sebaceous gland carcinoma of the head and neck: the Princess Margaret Hospital experience. Head Neck 2012 0.81
40 A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002 0.79
41 Clonogenic survival and cytokinesis-blocked binucleation of skin fibroblasts and normal tissue complications in soft tissue sarcoma patients treated with preoperative radiotherapy. Radiother Oncol 2004 0.79
42 Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers. Cancer Med 2014 0.79
43 Spiradenocarcinoma arising from a spiradenocylindroma: unusual case with lymphoepithelioma-like areas. J Cutan Med Surg 2009 0.78
44 Point-of-care outcome assessment in the cancer clinic: audit of data quality. Radiother Oncol 2010 0.78
45 Medial mandibulotomies: is there sufficient space in the midline to allow a mandibulotomy without compromising the dentition? J Otolaryngol Head Neck Surg 2013 0.77
46 Indications and outcomes of radiation therapy for skin cancer of the head and neck. Clin Plast Surg 2009 0.76
47 The introduction and evaluation of mobile devices to improve access to patient records: a catalyst for innovation and collaboration at BCCA. Stud Health Technol Inform 2013 0.75
48 Patterns of failure and histopathologic outcome predictors following definitive radiotherapy and planned neck dissection with residual disease. Head Neck 2011 0.75
49 Results of radiotherapy for primary subglottic squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2002 0.75